• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤发生发展及治疗中代谢重编程的见解

Insights into Metabolic Reprogramming in Tumor Evolution and Therapy.

作者信息

Chiu Ching-Feng, Guerrero Jonathan Jaime G, Regalado Ric Ryan H, Zhou Jiayan, Notarte Kin Israel, Lu Yu-Wei, Encarnacion Paolo C, Carles Cidne Danielle D, Octavo Edrian M, Limbaroc Dan Christopher I, Saengboonmee Charupong, Huang Shih-Yi

机构信息

Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei 110301, Taiwan.

Taipei Medical University Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110301, Taiwan.

出版信息

Cancers (Basel). 2024 Oct 17;16(20):3513. doi: 10.3390/cancers16203513.

DOI:10.3390/cancers16203513
PMID:39456607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506062/
Abstract

Cancer remains a global health challenge, characterized not just by uncontrolled cell proliferation but also by the complex metabolic reprogramming that underlies its development and progression. This review delves into the intricate relationship between cancer and its metabolic alterations, drawing an innovative comparison with the cosmological concepts of dark matter and dark energy to highlight the pivotal yet often overlooked role of metabolic reprogramming in tumor evolution. It scrutinizes the Warburg effect and other metabolic adaptations, such as shifts in lipid synthesis, amino acid turnover, and mitochondrial function, driven by mutations in key regulatory genes. This review emphasizes the significance of targeting these metabolic pathways for therapeutic intervention, outlining the potential to disrupt cancer's energy supply and signaling mechanisms. It calls for an interdisciplinary research approach to fully understand and exploit the intricacies of cancer metabolism, pointing toward metabolic reprogramming as a promising frontier for developing more effective cancer treatments. By equating cancer's metabolic complexity with the enigmatic nature of dark matter and energy, this review underscores the critical need for innovative strategies in oncology, highlighting the importance of unveiling and targeting the "dark energy" within cancer cells to revolutionize future therapy and research.

摘要

癌症仍然是一项全球性的健康挑战,其特征不仅在于细胞的无节制增殖,还在于其发展和进展背后复杂的代谢重编程。本综述深入探讨了癌症与其代谢改变之间的复杂关系,通过与暗物质和暗能量的宇宙学概念进行创新性比较,以突出代谢重编程在肿瘤演变中关键但往往被忽视的作用。它审视了瓦氏效应以及其他代谢适应性变化,如由关键调控基因突变驱动的脂质合成、氨基酸周转和线粒体功能的改变。本综述强调了针对这些代谢途径进行治疗干预的重要性,概述了破坏癌症能量供应和信号传导机制的潜力。它呼吁采用跨学科研究方法来全面理解和利用癌症代谢的复杂性,指出代谢重编程是开发更有效癌症治疗方法的一个有前景的前沿领域。通过将癌症的代谢复杂性与暗物质和能量的神秘本质相提并论,本综述强调了肿瘤学中创新策略的迫切需求,突出了揭示和靶向癌细胞内“暗能量”以革新未来治疗和研究的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696e/11506062/0906468ba328/cancers-16-03513-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696e/11506062/c8c0f10bb797/cancers-16-03513-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696e/11506062/0906468ba328/cancers-16-03513-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696e/11506062/c8c0f10bb797/cancers-16-03513-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696e/11506062/0906468ba328/cancers-16-03513-g002.jpg

相似文献

1
Insights into Metabolic Reprogramming in Tumor Evolution and Therapy.肿瘤发生发展及治疗中代谢重编程的见解
Cancers (Basel). 2024 Oct 17;16(20):3513. doi: 10.3390/cancers16203513.
2
The role of metabolic reprogramming in liver cancer and its clinical perspectives.代谢重编程在肝癌中的作用及其临床前景。
Front Oncol. 2024 Nov 14;14:1454161. doi: 10.3389/fonc.2024.1454161. eCollection 2024.
3
The role of dysregulated metabolism and associated genes in gastric cancer initiation and development.代谢失调及相关基因在胃癌发生发展中的作用。
Transl Cancer Res. 2024 Jul 31;13(7):3854-3868. doi: 10.21037/tcr-23-2244. Epub 2024 Jul 22.
4
p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect.p53 调控癌症代谢:揭示逆转瓦博格效应的策略。
Bull Math Biol. 2024 Aug 29;86(10):124. doi: 10.1007/s11538-024-01346-5.
5
Unraveling the intricacies of cancer-associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk.解析癌症相关成纤维细胞的复杂性:代谢重编程与肿瘤微环境相互作用的全面综述。
APMIS. 2024 Dec;132(12):906-927. doi: 10.1111/apm.13447. Epub 2024 Jun 14.
6
Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.将肿瘤糖酵解与癌症中的免疫逃逸联系起来:新出现的概念和治疗机会。
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):212-220. doi: 10.1016/j.bbcan.2017.04.002. Epub 2017 Apr 8.
7
Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects.食管癌微环境中的代谢重编程与免疫变化:未来方向与前景
Front Immunol. 2025 Jan 24;16:1524801. doi: 10.3389/fimmu.2025.1524801. eCollection 2025.
8
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.肿瘤免疫微环境中的代谢重编程:对免疫细胞功能的影响及其治疗意义。
Cancer Lett. 2024 Aug 10;597:217076. doi: 10.1016/j.canlet.2024.217076. Epub 2024 Jun 19.
9
Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology.黑色素瘤代谢:皮肤肿瘤学中的分子机制与治疗意义。
Cancer Med. 2024 Nov;13(21):e70386. doi: 10.1002/cam4.70386.
10
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.解析肿瘤微环境:洞察癌症转移和治疗策略。
Cancer Lett. 2024 Jun 1;591:216894. doi: 10.1016/j.canlet.2024.216894. Epub 2024 Apr 16.

引用本文的文献

1
The synergistic effect of 2-deoxy-D-glucose and cytarabine on mitochondria of stem-like cells derived from KG1-a.2-脱氧-D-葡萄糖与阿糖胞苷对源自KG1-a的干细胞样细胞线粒体的协同作用。
Leuk Res Rep. 2025 Aug 11;24:100537. doi: 10.1016/j.lrr.2025.100537. eCollection 2025.
2
UBD-mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion.泛素-蛋白酶体依赖性降解(UBD)介导的糖酵解重编程促进卵巢癌免疫逃逸中的M2巨噬细胞极化。
J Cell Commun Signal. 2025 Jul 21;19(3):e70034. doi: 10.1002/ccs3.70034. eCollection 2025 Sep.
3
Genetic, epigenetic, and molecular determinants of multiple myeloma and precursor plasma cell disorders: a pathophysiological overview.

本文引用的文献

1
Metabolic Function and Therapeutic Potential of CD147 for Hematological Malignancies: An Overview.CD147 在血液系统恶性肿瘤中的代谢功能及治疗潜力:综述。
Int J Mol Sci. 2024 Aug 23;25(17):9178. doi: 10.3390/ijms25179178.
2
A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy.一项纳米维朗拉治疗晚期胆道癌患者的 II 期安慰剂对照研究:既往接受过全身化疗。
Clin Cancer Res. 2024 Sep 13;30(18):3990-3995. doi: 10.1158/1078-0432.CCR-24-0461.
3
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma.
多发性骨髓瘤和前驱浆细胞疾病的遗传、表观遗传及分子决定因素:病理生理学概述
Med Oncol. 2025 Jun 3;42(7):234. doi: 10.1007/s12032-025-02807-0.
4
Tumor hypoxia shapes natural killer cell anticancer activities.肿瘤缺氧塑造自然杀伤细胞的抗癌活性。
J Mol Med (Berl). 2025 May 30. doi: 10.1007/s00109-025-02557-6.
5
Correction: Chiu et al. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy. 2024, , 3513.更正:邱等人。肿瘤进化与治疗中代谢重编程的见解。2024年,,3513。 (注:原文中存在格式不完整等问题,翻译尽量忠实于原文呈现的内容)
Cancers (Basel). 2025 Feb 18;17(4):686. doi: 10.3390/cancers17040686.
海洋吡咯衍生物 MP1 作为一种新型的抗癌药物,用于治疗 3 组 MYC 扩增型髓母细胞瘤。
J Exp Clin Cancer Res. 2024 Jan 11;43(1):18. doi: 10.1186/s13046-024-02944-w.
4
From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy.从复杂性到清晰度:通过肿瘤微环境的视角揭示肿瘤异质性,为创新癌症治疗提供思路。
Histochem Cell Biol. 2024 Apr;161(4):299-323. doi: 10.1007/s00418-023-02258-6. Epub 2024 Jan 8.
5
Nutrigenomics and redox regulation: Concepts relating to the Special Issue on nutrigenomics.营养基因组学与氧化还原调控:与营养基因组学特刊相关的概念。
Redox Biol. 2023 Dec;68:102920. doi: 10.1016/j.redox.2023.102920. Epub 2023 Oct 4.
6
Social Determinants of Cancer Disparities.癌症差异的社会决定因素。
Ann Surg Oncol. 2023 Dec;30(13):8094-8104. doi: 10.1245/s10434-023-14200-0. Epub 2023 Sep 18.
7
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.肿瘤微环境中的脂质代谢重编程:从机制到治疗。
J Hematol Oncol. 2023 Sep 12;16(1):103. doi: 10.1186/s13045-023-01498-2.
8
Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance.癌症相关成纤维细胞在治疗抵抗中的潜在机制。
Biomed Pharmacother. 2023 Oct;166:115425. doi: 10.1016/j.biopha.2023.115425. Epub 2023 Sep 4.
9
Emerging therapies in cancer metabolism.癌症代谢中的新兴治疗方法。
Cell Metab. 2023 Aug 8;35(8):1283-1303. doi: 10.1016/j.cmet.2023.07.006.
10
Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance.葡萄糖代谢重编程在乳腺癌进展和耐药中的作用
Cancers (Basel). 2023 Jun 28;15(13):3390. doi: 10.3390/cancers15133390.